Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Vertex Pharmaceuticals Appoints Jonathan Poole As Chief Financial Officer

PUBLIC · VRTXSep 02, 2026•6 days ago

Position

Chief Operating Officer

Company

Vertex Pharmaceuticals

Charles F. Wagner, Jr.
BostonBiotechnologyHealth CareTherapeutics

Description

Vertex Pharmaceuticals announced the appointment of Jonathan Poole as Executive Vice President and Chief Financial Officer, effective January 1, 2027. This strategic move aims to strengthen the financial management team amid ongoing growth initiatives.

Company Information

Company

Vertex Pharmaceuticals

Location

Boston, Massachusetts, United States

About

Vertex is a global biotechnology company focused on innovative medicines for serious diseases. The company is known for its commitment to scientific innovation and has developed therapies that address critical health challenges. Vertex is particularly invested in treatments related to genetic and rare diseases. Its mission is to improve the lives of patients with severe and life-threatening conditions.

Don't miss Vertex Pharmaceuticals's next move

Get an email the moment Vertex Pharmaceuticals changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Jennifer
Likely contact at this company
••••••••@••••••••

See Jennifer's verified email →

Grace
Senior decision-maker at this company
••••••••@••••••••

See Grace's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Vertex Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Vertex Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.